Imperial Brands Black Buffalo Acquisition Expands U.S. Oral Portfolio

Imperial Brands Black Buffalo acquisition is strengthening the company’s position in the evolving U.S. modern oral category. Imperial Brands announced on 27 May 2026 that it had acquired Black Buffalo, a tobacco-alternative oral brand offering long-cut and pouch products designed for adult consumers of traditional moist smokeless tobacco.

The transaction has an initial consideration of US$150 million, with an additional deferred amount based on performance over three years and other criteria. Black Buffalo has become part of Imperial Brands’ portfolio effective immediately.

The acquisition gives Imperial a broader U.S. oral portfolio alongside its existing Zone nicotine-pouch business.

Why the Black Buffalo Acquisition Matters

Black Buffalo was established in 2015 and has developed tobacco-alternative long-cut and pouch products intended to replicate elements of the taste, ritual and branding associated with traditional moist smokeless tobacco without tobacco leaf or stem.

Imperial Brands said Black Buffalo appeals to a different consumer segment from Zone, its existing U.S. range of flavoured nicotine pouches.

This makes the transaction strategically different from simply adding another nicotine-pouch brand. Instead, Imperial is expanding into a differentiated oral product proposition.

Imperial Brands Builds a Broader U.S. Oral Portfolio

Imperial entered the U.S. modern oral category through its 2023 acquisition of a range of nicotine pouches from TJP Labs. The products were subsequently relaunched under the Zone brand in 2024.

Zone has since become an important part of Imperial’s U.S. next-generation product strategy.

The addition of Black Buffalo gives Imperial another oral format and allows the company to participate across different segments of the evolving U.S. oral market.

Imperial’s own brand information describes Zone as a modern oral nicotine pouch brand, while Black Buffalo provides a differentiated tobacco-alternative long-cut and pouch proposition.

Black Buffalo Brings a Different Product Proposition

Black Buffalo’s products are manufactured in North Carolina using U.S.-grown barn-cured leafy greens, pharmaceutical-grade nicotine and food-grade flavours, according to Imperial Brands. The company says Black Buffalo developed its proprietary farm-to-can process through extensive research and development.

The company also states that Black Buffalo has completed more than 25,000 hours of research and development focused on its smokeless-tobacco-alternative products.

For Imperial, this product differentiation can complement rather than directly duplicate its existing Zone portfolio.

U.S. Modern Oral Market Continues to Develop

The acquisition comes as the U.S. modern oral nicotine category continues to attract investment from major nicotine companies.

Imperial’s 2026 half-year reporting said its U.S. Zone business had continued to build distribution, with Zone available in 109,000 stores and holding a reported 2.8% share of the growing category during the period.

The company has also continued launching new Zone flavours and strengthening its U.S. distribution strategy.

The Black Buffalo transaction therefore adds another brand to an oral portfolio that Imperial has been developing over several years.

Product Differentiation Is Becoming More Important

Competition in the modern oral category is increasingly extending beyond nicotine strength alone.

Manufacturers are developing products differentiated by:

• Product format
• Flavour
• Moisture characteristics
• Texture
• Nicotine delivery
• Portion size
• Packaging
• Consumer experience

Black Buffalo’s positioning around the traditional moist smokeless tobacco experience illustrates this broader product-development strategy.

For B2B manufacturers, these developments also increase the importance of consistent raw-material specifications and technical documentation.

Implications for Nicotine Raw-Material Suppliers

The expansion of oral nicotine products can have implications throughout the upstream supply chain.

Manufacturers developing different oral formats may require nicotine raw materials with clearly defined:

• Purity
• Assay
• Impurity profile
• Batch consistency
• Traceability
• Certificate of Analysis
• Safety documentation
• Packaging specifications

For example, McCoy NIC’s Pure Nicotine 99.9% page provides information on assay, specifications, batch-specific CoA and traceability for qualified B2B buyers.

Quality and Batch Consistency

As oral nicotine manufacturers develop multiple product formats, consistency between raw-material batches can become an important quality consideration.

A supplier qualification process may involve reviewing:

• Current CoA
• Product specification
• Analytical methods
• Batch identification
• Manufacturing information
• Storage requirements
• Export documentation
• Applicable compliance information

McCoy NIC’s certifications and compliance documents page provides information about its current quality and compliance documentation.

Regulatory Environment Remains Important

The commercial expansion of oral nicotine products is taking place alongside increased regulatory scrutiny.

In the United States, new nicotine-pouch products continue to go through the FDA’s regulatory process. In August 2026, the FDA authorized 11 additional ZYN ULTRA nicotine pouch products, adding another significant development to the U.S. category.

This means manufacturers need to consider regulatory requirements alongside product development and market strategy.

Companies expanding internationally also need to remember that regulatory treatment can differ substantially between the United States, Europe and individual national markets.

Global Nicotine Pouch Competition Is Increasing

The Black Buffalo transaction is part of a wider trend in which large nicotine companies are investing in modern oral products.

Our article Nicotine Pouch Market Continues to Expand Across Global Markets covers the broader growth of the category and the increasing competition among manufacturers.

Another useful related article is Nicotine Pouch Category Growth Cools From Post-Pandemic Highs, which examines how the category is moving toward a more mature growth phase.

Imperial’s Modern Oral Strategy Continues to Expand

Black Buffalo is not the only modern oral acquisition made by Imperial Brands in 2026.

On 7 September 2026, Imperial announced the acquisition of Yoik Group AB, owner of Swedish modern oral brand Helwit. Imperial said the transaction would more than double its existing modern oral market share in Sweden, Europe’s largest oral nicotine market.

Together, the Black Buffalo and Helwit transactions show that modern oral products remain an important component of Imperial’s next-generation product strategy.

What This Means for the Nicotine Industry

The Black Buffalo transaction highlights several broader trends in the nicotine industry:

1. Large companies are expanding modern oral portfolios.
2. Product differentiation is becoming increasingly important.
3. Nicotine pouches remain a major area of investment.
4. Alternative oral formats are attracting strategic attention.
5. Regulatory requirements continue to influence product development.
6. Raw-material consistency and technical documentation remain important.
7. Acquisitions are being used to accelerate entry into established categories.

These developments could create additional opportunities for manufacturers, ingredient suppliers, testing laboratories and other businesses supporting the international nicotine supply chain.

Importance of Reliable Nicotine Supply

As manufacturers expand their oral portfolios, reliable raw-material sourcing becomes increasingly important.

A qualified B2B nicotine supplier can support manufacturers through consistent specifications, batch documentation and traceability.

McCoy NIC’s nicotine extraction process explains its five-stage route from graded tobacco material to high-purity nicotine, including batch release and analytical testing.

For buyers comparing tobacco-derived and non-tobacco-derived nicotine, the tobacco-derived nicotine page also provides information on natural origin, 99.9% assay and lot traceability.

What Manufacturers Should Watch Next

The U.S. oral nicotine market is likely to remain an important area of industry activity.

Manufacturers and suppliers should monitor:

• New oral product launches
• FDA regulatory decisions
• Nicotine strength developments
• New flavours and formulations
• Retail distribution
• M&A activity
• Product quality requirements
• Supply-chain traceability
• International regulatory differences

For a broader view of industry developments, our Global Nicotine Industry 2026 article covers the shift toward product development, scientific evaluation and regulatory readiness.